Johnson & Johnson   4Q Revenues: $18.3 billion (-1%) 4Q Earnings: $2.5 billion (-29%) FY Revenues: $74.3 billion (+4%) FY Earnings: $16.3 billion (+18%) Comments: Worldwide sales for the year were $74.3 billion, up 4%. Operational results increased 4% and the negative impact of currency was 4.5%. Domestic sales increased 7% while international sales decreased 7%. Worldwide Pharmaceutical sales were $32.3 billion for the year, up 15%, driven by new products and core products including: OL...